Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study
Kamarudin Ahmad, Zoriah Aziz
Journal of Ethnopharmacology (2012) Vol. 141, Iss. 1, pp. 446-450
Closed Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan, Muzaimi Mustapha, Visweswaran Navaratnam, et al.
Neuroscience & Biobehavioral Reviews (2012) Vol. 37, Iss. 2, pp. 138-151
Closed Access | Times Cited: 342
Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam
Drug and Alcohol Dependence (2014) Vol. 139, pp. 132-137
Closed Access | Times Cited: 224
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam
Brain Research Bulletin (2016) Vol. 126, pp. 41-46
Closed Access | Times Cited: 187
Kratom use and mental health: A systematic review
Marc T. Swogger, Zach Walsh
Drug and Alcohol Dependence (2017) Vol. 183, pp. 134-140
Closed Access | Times Cited: 133
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Nurul H.M. Yusoff, Farah Wahida Suhaimi, Raja Vadivelu, et al.
Addiction Biology (2014) Vol. 21, Iss. 1, pp. 98-110
Closed Access | Times Cited: 127
Pharmacokinetics of mitragynine in man
Winai Wananukul, Satariya Trakulsrichai, Korbtham Sathirakul, et al.
Drug Design Development and Therapy (2015), pp. 2421-2421
Open Access | Times Cited: 127
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study
Darika Saingam, Sawitri Assanangkornchai, Alan Geater, et al.
International Journal of Drug Policy (2012) Vol. 24, Iss. 4, pp. 351-358
Closed Access | Times Cited: 116
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113
Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Social Functioning of Kratom(Mitragyna speciosa)Users in Malaysia
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 2, pp. 125-131
Closed Access | Times Cited: 86
Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam, Surash Ramanathan, Sreenivasan Sasidharan, et al.
Journal of Ethnopharmacology (2013) Vol. 146, Iss. 3, pp. 815-823
Closed Access | Times Cited: 79
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 3
Open Access | Times Cited: 78
Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Jun Lü, Heming Wei, Jian Wu, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e115648-e115648
Open Access | Times Cited: 67
Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun, Zurina Hassan, Visweswaran Navaratnam, et al.
Psychopharmacology (2015) Vol. 232, Iss. 13, pp. 2227-2238
Closed Access | Times Cited: 65
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study.
Balasingam Vicknasingam, Weng-Tink Chooi, Azlan Abdul Rahim, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 2, pp. 229-238
Closed Access | Times Cited: 59
Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review
Jonathan Schimmel, Richard C. Dart
Drugs (2020) Vol. 80, Iss. 3, pp. 263-283
Closed Access | Times Cited: 53
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top